| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $2.18K | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $3.30M | $2.50M | $1.59M | $3.30M | $9.09M |
| R&D | – | – | – | – | – |
| SG&A | $1.58M | $2.50M | $1.59M | $3.30M | $9.09M |
| Operating Income | -$3.30M | -$2.50M | -$1.59M | -$3.30M | -$9.09M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$2.48M | -$2.12M | -$2.01M | -$4.20M | -$10.24M |
| EPS (basic) | -0.0020 | -0.0060 | -0.0060 | -0.0100 | -0.0700 |
| EPS (diluted) | -0.0020 | -0.0060 | -0.0060 | -0.0100 | -0.0700 |
| Shares (diluted) | $1.32B | $359.57M | $359.38M | $302.89M | $140.34M |